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Abstract. Magnetic Resonance Imaging (MRI) is widely used for screen-
ing and staging prostate cancer. However, many prostate cancers have
subtle features which are not easily identifiable on MRI, resulting in
missed diagnoses and alarming variability in radiologist interpretation.
Machine learning models have been developed in an effort to improve can-
cer identification, but current models localize cancer using MRI-derived
features, while failing to consider the disease pathology characteristics
observed on resected tissue. In this paper, we propose CorrSigNet, an au-
tomated two-step model that localizes prostate cancer on MRI by cap-
turing the pathology features of cancer. First, the model learns MRI
signatures of cancer that are correlated with corresponding histopathol-
ogy features using Common Representation Learning. Second, the model
uses the learned correlated MRI features to train a Convolutional Neu-
ral Network to localize prostate cancer. The histopathology images are
used only in the first step to learn the correlated features. Once learned,
these correlated features can be extracted from MRI of new patients
(without histopathology or surgery) to localize cancer. We trained and
validated our framework on a unique dataset of 75 patients with 806
slices who underwent MRI followed by prostatectomy surgery. We tested
our method on an independent test set of 20 prostatectomy patients (139
slices, 24 cancerous lesions, 1.12M pixels) and achieved a per-pixel sen-
sitivity of 0.81, specificity of 0.71, AUC of 0.86 and a per-lesion AUC
of 0.96 ± 0.07, outperforming the current state-of-the-art accuracy in
predicting prostate cancer using MRI.
Keywords: Computer Aided Diagnosis · Common Representation Learn-
ing · MRI · Histopathology Images · Prostate Cancer
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1 Introduction
Early localization of prostate cancer from MRI is crucial for successful diagnosis
and local therapy. However, subtle differences between benign conditions and
cancer on MRI often make human interpretation challenging, leading to missed
diagnoses and an alarming variability in radiologist interpretation. Human inter-
pretation of prostate MRI suffers from low inter-reader agreement (0.46-0.78)[1]
and high variability in reported sensitivity (58-98%) and specificity (23-87%) [2].
Predictive models can help standardize radiologist interpretation, but cur-
rent models [3–8] often learn from MRI only, without considering the disease
pathology characteristics. These approaches derive MRI features that are agnos-
tic to the biology of the tumor. Moreover, current predictive models mostly use
inaccurate labels (either from biopsies [6] that suffer from sampling errors, or
cognitive registration of pre-operative MRI with digital histopathology images
of surgical specimens, where a radiologist retrospectively outlines the lesions on
MRI [4]). MRI under-estimates the tumor size [9], making outlines on MRI alone
insufficient to capture the entire extent of disease. Furthermore, it is challenging
to outline the ˜20% of tumors that are not clearly seen on MRI, even when
using histopathology images as reference [1]. These MRI-based models use a
variety of techniques including traditional classifiers with hand-crafted and ra-
diomic features [3,5,7], as well as deep learning based models [4,8]. The current
state-of-the-art approach [4] to predict a cancer probability map for the entire
prostate uses a Holistically Nested Edge Detection (HED) [10] algorithm.
In this paper, we propose CorrSigNet, a two-step approach for predicting
prostate cancer using MRI. First, CorrSigNet leverages spatially aligned radiol-
ogy and histopathology images of prostate surgery patients to learn MRI cancer
signatures that correlate with features extracted from the histopathology im-
ages. Second, CorrSigNet uses these correlated MRI signatures to train a predic-
tive model for localizing cancer when histopathology images are not available,
e.g. before surgery. This approach enables learning MRI signatures that capture
tumor biology information from surgery patients with histopathology images,
and then translating those learned signatures for prediction in patients without
surgery/biopsy. Prior studies lack such correlation analysis of the two modali-
ties. Our approach shows improved prostate cancer prediction compared to the
current state-of-the-art method [4].
2 Proposed Method
2.1 Dataset
We used 95 prostate surgery patients with pre-operative multi-parametric MRI
(T2-weighted and Apparent Diffusion Coefficient) and post-operative digitized
histopathology images. Custom 3D printed molds were used to ensure that ex-
cised prostate tissue was sectioned in the same plane as the T2-weighted (T2W)
MRI. An expert pathologist annotated cancer on the histopathology images. We
spatially aligned the pre-operative MRI and digitized histopathology images of
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the excised tissue via the state-of-the-art RAPSODI registration platform [11].
RAPSODI achieved a Dice similarity coefficient of 0.98±0.01 for the prostate,
prostate boundary Hausdorff distance of 1.71±0.48 mm, and urethra deviation
of 2.91±1.25 mm between registered histopathology images and MRI. Such care-
ful registration of radiology and pathology images of the prostate enabled (1)
correlation analysis of the two modalities at a pixel-level, and (2) accurate map-
ping of cancer labels from pathology to radiology images. We considered multiple
slices per patient (average 7 slices/patient) irrespective of cancer size. Slices with
missing cancer annotations were discarded during training. The dataset included
some patients with cancer that had extra prostatic extensions, but our analysis
was focused only on cancers inside the prostate.
2.2 Data Pre-processing
We smoothed the histopathology images with a Gaussian filter with σ = 0.25
to prevent downsampling artifacts, padded and then downsampled them to
224 × 224, resulting in an X-Y resolution of 0.29 × 0.29 mm2. We projected
and resampled the T2W and ADC images, prostate masks, and cancer labels on
the corresponding downsampled histopathology images, such that they also had
the same X-Y resolution of 0.29 × 0.29 mm2. This ensured that each pixel in
each modality represented the same physical area.
Since MRI intensities vary significantly between scanners and scanning pro-
tocols, we standardized the T2W and ADC intensities using the histogram align-
ment approach proposed by Nyu´l et al. [12]. We used prostate masks to standard-
ize intensities within the prostate, and then applied the learned transformation
to the image region beyond the prostate. After intensity standardization, we
normalized the intensities to have zero mean and standard deviation of 1.
We randomly split the 95 patients to create our train, validation, and test
sets with 66, 9, and 20 patients respectively. After horizontal flipping based data
augmentation, the train and validation sets had 700 and 106 slices respectively.
The test set included 139 slices, 24 cancerous lesions, 1.12M pixels in the prostate
with 9% cancer pixels. We performed MRI scale standardization on the train set,
and used the learned histograms to standardize the validation and test sets. We
followed a similar strategy for MRI intensity normalization.
2.3 Learning correlated features
Feature extraction:We extracted features from the T2W, ADC, and histopathol-
ogy images by passing them through the first two convolutional layers of a
pre-trained VGG-16 architecture [13]. Thus, each 224 × 224 image yielded a
224×224×64 representation, generating 64 features per pixel. We sampled pix-
els from within the prostate, and concatenated the T2W and ADC features to
form the MRI representation per pixel. Thus, for each pixel, we had the MRI
representation Ri ∈ R128 and the histopathology representation Pi ∈ R64.
Common Representation learning: We trained a Correlational Neural Net-
work architecture (CorrNet) [14] to learn common representations from MRI
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and histopathology features per pixel. Given N pixels, each pixel input Zi to the
CorrNet model had two views: the MRI feature representation for pixel i, Ri,
and the histopathology feature representation for pixel i, Pi. We used a fully-
connected CorrNet model with a single hidden layer, where the hidden layer
H(Zi) ∈ Rk was computed as:
(1)H(Zi) = WRi + V Pi + b
where W ∈ Rk×128, V ∈ Rk×64 and b ∈ Rk×1. The reconstructed output Z ′i was
computed from the hidden layer as:
(2)Z ′i = [W
′H(Zi), V ′H(Zi)] + b′
where W ′ ∈ R128×k, V ′ ∈ R64×k and b′ ∈ R(128+64)×1. In contrast to the original
CorrNet model, we did not use any non-linear activation function. We learned the
parameters θ = {W,V,W ′, V ′, b, b′} of the system by minimizing the following
objective function, as detailed in [14]:
J(θ) =
N∑
i=1
[L(Zi, H(Zi)) +L(Zi, H(Ri)) +L(Zi, H(Pi))− λcorr(H(Ri), H(Pi))]
(3)
(4)
corr(H(Ri), H(Pi))
=
∑N
i=1[(H(Ri)−H(R))(H(Pi)−H(P )]√∑N
i=1(H(Ri)−H(R))2
∑N
i=1(H(Pi)−H(P ))2
where L is the reconstruction error, λ is the scaling parameter to determine the
relative weight of the correlation error with respect to the reconstruction errors,
H(R) is the mean hidden representation of the 1st view and H(P ) is the mean
hidden representation of the 2nd view. Thus, the CorrNet model (i) minimizes
the self and cross reconstruction errors, and (ii) maximizes the correlation be-
tween the hidden representations of the two views. Training CorrNet using pixel
representations from within the prostate gave ample training samples to optimize
the model, and to learn differences between cancer and non-cancer pixels.
After the CorrNet model was trained, we used the learned weights W, b to
project the MRI feature representations Ri onto the k dimensional hidden space
to form CorrNet representations of the input MRI. The CorrNet representations
are correlated with the corresponding histopathology features, and once trained,
can be constructed even in the absence of histopathology images. Figure 1 shows
the pipeline for learning common representations.
Training: From the 66 patients in the training cohort, we sampled all the cancer
pixels from within the prostate, and randomly sampled an equal number of non-
cancer pixels, also from within the prostate, thereby generating a training set of
≈ 1.2M pixels, with equal number of cancer and non-cancer pixels. This ensured
that we train the CorrNet with a balanced dataset of two classes. We used λ = 2
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Fig. 1: Learning correlated representations from spatially aligned MRI and
histopathology images, and then constructing the correlated (CorrNet) repre-
sentations from MRI alone using learned weights.
Fig. 2: Five-dimensional CorrNet representations for one example MRI slice
Fig. 3: HED-branch-3 model for predicting cancer probability maps.
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to weigh the cross-correlation error higher than the reconstruction errors. We
chose a squared error loss L for the reconstruction errors. We trained the CorrNet
model with varying hidden layer dimensions, namely: k ∈ {1, 3, 5, 15, 30}. For
each k, we used a learning rate η = 10−5, and 300 training epochs. Figure 2
shows CorrNet representations of an example MRI slice, with k = 5.
2.4 Prediction of prostate cancer extent
We modified the Holistically Nested Edge Detection (HED) architecture [10] to
predict cancer probability maps for the entire prostate. We considered two mod-
ified versions of HED: (1) HED-3, and (2) HED-branch-3. The HED-3 model
evaluates how well CorrNet representations alone perform in predicting cancer,
while the HED-branch-3 model evaluates how well CorrNet representations com-
bined with T2W and ADC images perform in predicting cancer. We represent our
model using correlated feature learning and HED-3 as CorrSigNet(k), and our
model with correlated feature learning and HED-branch-3 as CorrSigNet(T2W,
ADC, k), where k is the CorrNet feature dimension. For example, CorrSigNet(5)
uses only 5 correlated features for prediction, whereas CorrSigNet (T2W, ADC,
5) uses the normalized T2W and ADC intensities in addition to 5 correlated
features for prediction. We chose a prediction model similar to the HED archi-
tecture because it is known to learn and combine multi-scale and multi-level
features, and has been successfully applied to anatomy segmentations from CT
scans [15–17], and to prostate cancer prediction [4].
In HED-3, we input three adjacent CorrNet slice representations of the
prostate and output predictions for only the central slice. This ensured that the
2D-HED model learned the 3D volumetric continuity from MRI/ histopathol-
ogy/ correlated features. This also helped in reducing false positive rates.
In HED-branch-3 (shown in Figure 3), we combined the CorrNet slice repre-
sentations together with the normalized T2W and ADC images as inputs to the
model. Similar to HED-3, we considered three adjacent slices for each input se-
quence (T2W, ADC, CorrNet representations), and predicted cancer probability
maps for the central slice only. However, in HED-branch-3 model, we processed
each input sequence independently using the first three blocks, concatenated the
three outputs from the three independent blocks, and processed the concate-
nated output using the next 2 blocks. Since the input sequences are processed
independently in the first three blocks, we had a total of 11 side outputs, which
were fused together using a Conv-1D layer to form the weighted fused output.
We computed balanced cross-entropy losses for each of the 12 outputs (11 side
outputs and 1 fused output) while training the architecture, but computed eval-
uation metrics only on the fused output. We used 3×3 kernels for all convolution
layers except the last Conv-1D layer. The number of filters in each layer is stated
in the legend in Figure 3. For both the HED-3 and HED-branch-3 models, we
added Batch Normalization in each block, before ReLU activation, as opposed
to the HED model used by [4] which used Batch Normalization in each layer.
No post-processing steps were performed on the prediction maps.
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Training: We trained both models using an Adam optimizer with an initial
learning rate η = 10−3, weight decay α = 0.1, epochs = 200 and early stopping.
3 Experimental Results
Quantitative Evaluation: We quantitatively evaluated our models on a per-
pixel and a per-lesion basis, with ground truth labels derived from pathologist
cancer annotations on registered histopathology images. For a direct comparison,
we reproduced the current state-of-the-art model [4] to the best of our under-
standing, and computed both pixel-level and lesion-level evaluation metrics of
this model on our test data (20 patients, 139 slices, 24 cancerous lesions, 1.12M
pixels in the prostate). It may be noted that the AUC numbers reported in [4]
are computed on a lesion level, and not on a pixel-level. Our pixel-level metrics
including all pixels within the prostate provide a more rigorous evaluation.
Pixel level analysis: We tested the performance of the CorrSigNet models with
Table 1: Pixel-level quantitative evaluation of CorrSigNet models
Model Sensitivity Specificity AUC
HED [4] (current state-of-the-art) 0.75 0.74 0.80
CorrSigNet(1) 0.72 0.78 0.81
CorrSigNet(3) 0.82 0.71 0.86
CorrSigNet(5) 0.77 0.77 0.86
CorrSigNet(15) 0.76 0.78 0.84
CorrSigNet(30) 0.75 0.81 0.85
CorrSigNet(T2W, ADC, 1) 0.73 0.79 0.83
CorrSigNet(T2W, ADC, 3) 0.70 0.85 0.86
CorrSigNet(T2W, ADC, 5) 0.81 0.72 0.86
CorrSigNet(T2W, ADC, 15) 0.78 0.78 0.86
CorrSigNet(T2W, ADC, 30) 0.83 0.71 0.86
different inputs and varying CorrNet feature dimension k using the following
pixel-level evaluation metrics (computed using 1.12M pixels in the prostate):
sensitivity, specificity, and AUC of the ROC curve, with a probability threshold
of 0.5. We note from Table 1 that CorrSigNet performs better than [4], with
consistently higher AUC numbers in pixel-level analysis. The sensitivity and
specificity numbers vary within the models. Our tests showed that at least 3
CorrNet features were necessary for improved performance over MRI alone. We
chose CorrSigNet (T2W, ADC, 5) as the optimum model, because it had high
sensitivity, specificity and AUC, with an optimum number of parameters. Be-
tween false positives and false negatives, we note that a false negative is more
detrimental than a false positive in the task of cancer prediction.
Lesion level analysis: We performed lesion-level analysis using the evaluation
method detailed in [4] and found that CorrSigNet(T2W, ADC, 5) achieved a
per-lesion AUC of 0.96 ± 0.07 compared to a per-lesion AUC of 0.92 ± 0.09 by
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[4] on the same test set.
Qualitative Evaluation: Figure 4 shows the same slice as in Figure 2 with
(a) (b) (c)
(d) (e) (f)
Fig. 4: Spatially aligned (a) T2W, (b) ADC, and (c) histopathology images.
Data obtained and processed as detailed in 2.1. Prediction results using (d) the
current state-of-the-art method [4], (e) our model CorrSigNet(5), and (f) our
model CorrSigNet(T2W, ADC, 5).
aligned T2W, ADC, and histopathology images, and prediction results using
current state-of-the-art method [4], our CorrSigNet(5) and CorrSigNet(T2W,
ADC, 5) models. It may be noted that [4] fails to detect the cancerous regions
on the left and right of the images, while the CorrNet representations alone can
identify the cancer regions, and when combined with T2W and ADC images,
they predict the cancer regions with high probability. It may also be noted that
CorrSigNet(T2W, ADC, 5) shows fewer false positives than [4]. This example
shows the strength of learning correlated MRI signatures in identifying subtle,
and sometimes MRI-invisible cancers. Figure 5 shows more example slices from
different patients, comparing the state-of-the-art approach [4] and our prediction
results with CorrSigNet(T2W, ADC, 5). We note that our model with correlated
features (1) can identify subtle and smaller cancer regions, (2) have better over-
lap with ground truth cancer labels, and (3) have fewer false positives.
4 Conclusion
In this paper, we presented a novel method to learn correlated signatures of
cancer from spatially aligned MRI and histopathology images of prostatectomy
surgical specimens, and then use these learned correlated signatures in predicting
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Fig. 5: (Top) Prediction results using the current state-of-the-art method [4].
(Bottom) Prediction results from our model CorrSigNet(T2W, ADC, 5).
prostate cancer extent from MRI. Quantitatively, our method improved perfor-
mance of automated prostate cancer localization (per-pixel AUC of 0.86, per-
lesion AUC of 0.96± 0.07), as compared to the current state-of-the-art method
[4] (per-pixel AUC 0.80, per-lesion 0.92 ± 0.09). Qualitatively, we found that
correlated features could capture subtle cancerous regions and sometimes MRI-
invisible cancers, had better overlap with ground truth labels, and fewer false
positives. Correlated features have the capability of capturing tumor biology
information from histopathology images in an unprecedented way, and these
features, once learned, can be extracted in patients without histopathology im-
ages. In future work, we intend to conduct experiments with augmented datasets
and in a cross-validation framework to boost the performance of our models.
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